Literature DB >> 25182295

Phosphaturic mesenchymal tumor, mixed connective tissue type, non-phosphaturic variant: report of a case and review of 32 cases from the Japanese published work.

Rie Honda1, Yuka Kawabata, Shusaku Ito, Fumihito Kikuchi.   

Abstract

Phosphaturic mesenchymal tumor, mixed connective tissue type (PMTMCT) is a rare neoplasm that can cause tumor-induced osteomalacia due to overproduction of a phosphaturic hormone, fibroblast growth factor 23 (FGF23). We report here a case of subcutaneous PMTMCT, non-phosphaturic variant, in the sole. We also review 32 Japanese cases of PMTMCT reported in detail. They occurred in 16 men and 15 women (one was unknown), with ages ranging 20-73 years (median, 48). Tumors were found in soft tissue, bone and sinuses in 17, 11 and four, respectively. A history of long-standing osteomalacia was noted in all cases except two non-phosphaturic variant cases. Serum FGF23 level was elevated in 11 of 12 cases examined. In terms of follow-up information, metastases were found in four patients, and two patients died of disease. In conclusion, PMTMCT is histologically a benign lesion; however, there may be rare metastatic and malignant cases. Wider recognition of the histological features of this unique neoplasm would aid its distinction from the large number of mesenchymal tumors for which it may be mistaken and should enable correct diagnosis of tumors with osteomalacia.
© 2014 Japanese Dermatological Association.

Entities:  

Keywords:  fibroblast growth factor 23; mixed connective tissue type; osteomalacia; phosphaturia; phosphaturic mesenchymal tumor; sole

Mesh:

Year:  2014        PMID: 25182295     DOI: 10.1111/1346-8138.12602

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  15 in total

Review 1.  Tumor-Induced Osteomalacia: an Up-to-Date Review.

Authors:  Anke H Hautmann; Matthias G Hautmann; Oliver Kölbl; Wolfgang Herr; Martin Fleck
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

2.  Successful Localization Using 68Ga-DOTATOC PET/CT of a Phosphaturic Mesenchymal Tumor Causing Osteomalacia in a Patient with Concurrent Follicular Lymphoma.

Authors:  Sejin Ha; Sujin Park; Hyunji Kim; Heounjeong Go; Seung Hun Lee; Ji Yoon Choi; Jung Yong Hong; Jin-Sook Ryu
Journal:  Nucl Med Mol Imaging       Date:  2018-09-12

3.  Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis.

Authors:  Jason K Wasserman; Bibianna Purgina; Chi K Lai; Denis Gravel; Alyssa Mahaffey; Diana Bell; Simion I Chiosea
Journal:  Head Neck Pathol       Date:  2016-01-12

4.  Ga-68 DOTATOC PET/CT-Guided Biopsy and Cryoablation with Autoradiography of Biopsy Specimen for Treatment of Tumor-Induced Osteomalacia.

Authors:  Majid Maybody; Ravinder K Grewal; John H Healey; Cristina R Antonescu; Louise Fanchon; Sinchun Hwang; Jorge A Carrasquillo; Assen Kirov; Azeez Farooki
Journal:  Cardiovasc Intervent Radiol       Date:  2016-05-05       Impact factor: 2.740

5.  Phosphaturic Mesenchymal Tumor.

Authors:  J C Benson; J A Trejo-Lopez; A M Nassiri; K Eschbacher; M J Link; C L Driscoll; R D Tiegs; J Sfeir; D R DeLone
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-19       Impact factor: 4.966

Review 6.  Phosphaturic Mesenchymal Tumor: 2 New Oral Cases and Review of 53 Cases in the Head and Neck.

Authors:  Hiba Qari; Aya Hamao-Sakamoto; Clay Fuselier; Yi-Shing Lisa Cheng; Harvey Kessler; John Wright
Journal:  Head Neck Pathol       Date:  2015-11-14

7.  Locally aggressive and multifocal phosphaturic mesenchymal tumors: two unusual cases of tumor-induced osteomalacia.

Authors:  Meghan Higley; Brooke Beckett; Sandra Schmahmann; Elizabeth Dacey; Erik Foss
Journal:  Skeletal Radiol       Date:  2015-09-04       Impact factor: 2.199

8.  Burosumab for the Treatment of Tumor-Induced Osteomalacia.

Authors:  Suzanne M Jan de Beur; Paul D Miller; Thomas J Weber; Munro Peacock; Karl Insogna; Rajiv Kumar; Frank Rauch; Diana Luca; Tricia Cimms; Mary Scott Roberts; Javier San Martin; Thomas O Carpenter
Journal:  J Bone Miner Res       Date:  2021-01-12       Impact factor: 6.741

9.  Phosphaturic mesenchymal tumor (PMT): exceptionally rare disease, yet crucial not to miss.

Authors:  Amir Ghorbani-Aghbolaghi; Morgan Angus Darrow; Tao Wang
Journal:  Autops Case Rep       Date:  2017-09-30

10.  A case report of phosphaturic mesenchymal tumor-induced osteomalacia.

Authors:  Weiqian Wu; Chongyang Wang; Jianwei Ruan; Feng Chen; Ningjun Li; Fanghu Chen
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.